Andreas Halvorsen – ROIV history
- Issuer:
- ROIVANT SCIENCES LTD
- Quarters tracked:
- 21 (Q4 2021 → Q1 2026)
- Current shares:
- 6,652,448
- Current value:
- $184.27M
- Peak shares:
- 88,238,700 (Q4 2021)
- Overall change:
- -92%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 6,652,448 | $184.27M | $27.70 | +209,257 | +3% |
| Q4 2025 | 6,443,191 | $139.82M | $21.70 | -17,151,640 | -73% |
| Q3 2025 | 23,594,831 | $356.99M | $15.13 | -10,642,948 | -31% |
| Q2 2025 | 34,237,779 | $385.86B | $11270.00 | 0 | 0% |
| Q2 2025 | 34,237,779 | $385.86M | $11.27 | -11,775,973 | -26% |
| Q1 2025 | 46,013,752 | $464.28M | $10.09 | 0 | 0% |
| Q1 2025 | 46,013,752 | $464.28B | $10090.00 | -1,796,208 | -4% |
| Q4 2024 | 47,809,960 | $565.59M | $11.83 | 0 | 0% |
| Q4 2024 | 47,809,960 | $565.59B | $11830.00 | -6,289,106 | -12% |
| Q3 2024 | 54,099,066 | $624.30M | $11.54 | -15,056,780 | -22% |
| Q2 2024 | 69,155,846 | $730.98M | $10.57 | -213,115 | 0% |
| Q1 2024 | 69,368,961 | $731.15M | $10.54 | 0 | 0% |
| Q4 2023 | 69,368,961 | $779.01B | $11230.00 | -4,065,340 | -6% |
| Q3 2023 | 73,434,301 | $857.71B | $11680.00 | -1,804,399 | -2% |
| Q2 2023 | 75,238,700 | $758.41B | $10080.00 | -13,000,000 | -15% |
| Q1 2023 | 88,238,700 | $651.20B | $7380.00 | 0 | 0% |
| Q4 2022 | 88,238,700 | $705.03M | $7.99 | 0 | 0% |
| Q3 2022 | 88,238,700 | $284.13M | $3.22 | 0 | 0% |
| Q2 2022 | 88,238,700 | $359.13M | $4.07 | 0 | 0% |
| Q1 2022 | 88,238,700 | $435.90M | $4.94 | 0 | 0% |
| Q4 2021 | 88,238,700 | $889.45M | $10.08 | — | NEW |